Mariner
TXG icon

Mariner’s 10x Genomics TXG Stock Holding History

Mariner’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$537K Buy
+14,027
New +$368K ﹤0.01% 2404
2026
Q1 		– Sell
-10,157
Closed -$166K – 3840
2025
Q4 		$166K Sell
10,157
-14,204
-58% -$215K ﹤0.01% 3227
2025
Q3 		$285K Sell
24,361
-16,562
-40% -$216K ﹤0.01% 2857
2025
Q2 		$474K Buy
40,923
+24,628
+151% +$224K ﹤0.01% 2377
2025
Q1 		$142K Buy
+16,295
New +$205K ﹤0.01% 3113
2024
Q4 		– Sell
-12,444
Closed -$281K – 3518
2024
Q3 		$281K Sell
12,444
-1,106
-8% -$22.9K ﹤0.01% 2632
2024
Q2 		$264K Sell
13,550
-4,837
-26% -$127K ﹤0.01% 2558
2024
Q1 		$690K Buy
18,387
+986
+6% +$43.3K ﹤0.01% 1788
2023
Q4 		$974K Sell
17,401
-207
-1% -$9.01K ﹤0.01% 1446
2023
Q3 		$726K Buy
17,608
+257
+1% +$13.4K ﹤0.01% 1524
2023
Q2 		$969K Buy
17,351
+212
+1% +$11.5K ﹤0.01% 1334
2023
Q1 		$954K Sell
17,139
-1,125
-6% -$52.5K ﹤0.01% 1291
2022
Q4 		$666K Buy
18,264
+4,019
+28% +$131K ﹤0.01% 1478
2022
Q3 		$406K Buy
14,245
+1,239
+10% +$47.2K ﹤0.01% 1551
2022
Q2 		$589K Buy
+13,006
New +$675K ﹤0.01% 1073
2022
Q1 		– Sell
-11,758
Closed -$1.75M – 1403
2021
Q4 		$1.75M Sell
11,758
-2,485
-17% -$381K 0.01% 686
2021
Q3 		$2.07M Sell
14,243
-924
-6% -$159K 0.01% 528
2021
Q2 		$2.97M Buy
+15,167
New +$2.74M 0.02% 402

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Mariner's TXG Position: Q2 2026 in Review

Mariner opened a new position in 10x Genomics (TXG) in Q2 2026: 14,027 shares worth $537K. The stake represents ﹤0.01% of the portfolio and ranks #2404 among its holdings. This is a return to the name: Mariner previously reported a position in TXG as recently as Q4 2025.

Mariner first reported a position in TXG in Q2 2021 and has held it in 18 quarters since. The position peaked at $2.97M in Q2 2021. 392 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Mariner held 14,027 shares of 10x Genomics worth $537K as of Q2 2026.
  • 10x Genomics was a new Mariner position in Q2 2026.
  • 10x Genomics made up ﹤0.01% of Mariner's portfolio in Q2 2026, its #2404 holding.
  • Mariner first reported a position in 10x Genomics in Q2 2021 and has held it in 18 quarters since.
  • Mariner's 10x Genomics position peaked at $2.97M in Q2 2021.
  • 392 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.